about
Influence of hypoxia on the domiciliation of mesenchymal stem cells after infusion into rats: possibilities of targeting pulmonary artery remodeling via cells therapies?Are osteoclasts needed for the bone anabolic response to parathyroid hormone? A study of intermittent parathyroid hormone with denosumab or alendronate in knock-in mice expressing humanized RANKL.Development of a new ELISA for serum periostin: evaluation of growth-related changes and bisphosphonate treatment in mice.Impaired musculoskeletal response to age and exercise in PPARβ(-/-) diabetic miceZoledronate effects on systemic and jaw osteopenias in ovariectomized periostin-deficient miceDiet and gene interactions influence the skeletal response to polyunsaturated fatty acidsPeriostin deficiency increases bone damage and impairs injury response to fatigue loading in adult miceA botulinum toxin-derived targeted secretion inhibitor downregulates the GH/IGF1 axisRegulation of beta catenin signaling and parathyroid hormone anabolic effects in bone by the matricellular protein periostinImaging techniques for evaluating bone microarchitecture.Preclinical mouse models for assessing axial compression of long bones during exercise.Adrenergic control of bone remodeling and its implications for the treatment of osteoporosis.Cathepsin K Controls Cortical Bone Formation by Degrading Periostin.Bone-Derived Factors: A New Gateway to Regulate Glycemia.Influence of Fatigue Loading and Bone Turnover on Bone Strength and Pattern of Experimental Fractures of the Tibia in Mice.Vertebral fracture assessment (VFA) with a densitometer predicts future fractures in elderly women unselected for osteoporosis.Various effects of antidepressant drugs on bone microarchitectecture, mechanical properties and bone remodeling.Bone Regulates Browning and Energy Metabolism Through Mature Osteoblast/Osteocyte PPARγ Expression.Comparative inhibition of the GH/IGF-I axis obtained with either the targeted secretion inhibitor SXN101959 or the somatostatin analog octreotide in growing male rats.Cortical and Trabecular Bone Microstructure Did Not Recover at Weight-Bearing Skeletal Sites and Progressively Deteriorated at Non-Weight-Bearing Sites During the Year Following International Space Station Missions.Leptin, central nervous system, and bone: influence of physical activity.Serum Levels of a Cathepsin-K Generated Periostin Fragment Predict Incident Low-Trauma Fractures in Postmenopausal Women Independently of BMD and FRAX.Development of a New Immunoassay for Human Cathepsin K-Generated Periostin Fragments as a Serum Biomarker for Cortical Bone.Interaction between LRP5 and periostin gene polymorphisms on serum periostin levels and cortical bone microstructure.Effects of long-term supplementation with omega-3 fatty acids on longitudinal changes in bone mass and microstructure in mice.Periostin action in bone.Doping dose of salbutamol and exercise training: impact on the skeleton of ovariectomized rats.Combined effects of exercise and propranolol on bone tissue in ovariectomized rats.Doping dose of salbutamol and exercise: deleterious effect on cancellous and cortical bones in adult rats.Dose effects of propranolol on cancellous and cortical bone in ovariectomized adult rats.Additive Genetic Effects on Circulating Periostin Contribute to the Heritability of Bone Microstructure.Within- and Across-Sex Inheritance of Bone Microarchitecture.Protective effect of beta blockers in postmenopausal women: influence on fractures, bone density, micro and macroarchitectureThe mode of bone conservation does not affect the architecture and the tensile properties of rat femursDeletion of β-adrenergic receptor 1, 2, or both leads to different bone phenotypes and response to mechanical stimulationCombined effects of zoledronate and mechanical stimulation on bone adaptation in an axially loaded mouse tibiaPeriostin expression contributes to cortical bone loss during unloadingNovel genetic models of osteoporosis by overexpression of human RANKL in transgenic miceThe C-Terminal Intact Forms of Periostin (iPTN) Are Surrogate Markers for Osteolytic Lesions in Experimental Breast Cancer Bone Metastasis
P50
Q24812198-C727F0AA-69BA-444E-8AED-F7D6AB2906F0Q34107428-861D3AB5-E78A-45A0-B2B7-BD9F73286136Q34122023-3D97C03B-CCE9-474D-ADD4-C4324CBC172AQ34551710-F2CE0DA9-10C0-4775-AD5C-52DC344252E5Q34626012-FF8BF0E7-F2F5-4591-A40B-3460B5114B41Q34703709-FEA823B8-54D3-4871-A274-349A5154F4BBQ35027916-5938C627-4E8F-4530-BD17-7703572D65E8Q36190743-2CD62EB9-D761-4929-818F-084832CFC99DQ36236285-D3BA86C6-2526-47F2-98B8-79DCEEE83C4EQ36404625-B9F629FD-21FC-4CF4-A1C8-B1C84272D46BQ36439848-FB1F099F-A9AF-494D-BCE8-B69546D89315Q37214296-BD0AF1BD-53A3-46C9-A45F-62108580D10DQ38891355-80FAB78D-405C-45BA-8241-6D4EC6A47F8BQ39004609-CA3A80A6-3B1E-4B5D-9018-938A65AC23FBQ39945856-F03F4210-5763-4D45-A227-23E593FEA1A8Q40087488-B3DBF7B2-660F-4A9A-878F-B12A7C5F2DADQ42615548-BB137057-8CB5-4FE3-94A9-E76E1F20FD5EQ42799259-FE74FECB-DFA1-4360-91CD-F652323C3E29Q45001570-AA76B6EA-E83D-44D7-A005-55A500B024DBQ46160867-429AC2BA-B4CE-475F-B4AB-4C0683E2D019Q46823091-7777436D-D0AE-4127-96FE-DC9C82947C0DQ48000943-6296883F-255D-4F4E-9FF2-932D31CE95B9Q48097959-426BB3AC-10CA-4EB0-9346-3B4E206F966BQ50077689-93DEC483-D3E5-4A81-9BAC-79727FE2FA52Q51535060-23EEACFF-5CDD-4567-B8D1-CDFF485976ACQ51560309-3F7219EF-8416-4AA3-A05E-E44914ABBEB8Q51754302-279233EA-2B38-4BC4-92C5-AB1E385002D2Q51769607-969089DD-9142-4874-97C5-87AE78091C4FQ51772800-E5E9ED42-E339-47CE-B4B6-1BD6F9AD01F6Q51802019-2C579AEE-480A-4CFD-ACF1-1D5791E9702DQ52951994-F8E186C5-62C3-4AD3-B561-6C056173B0C4Q52968810-8F007E80-000F-46A2-B13E-50DBBC8D4252Q79836323-DC7F4D1F-B960-487E-9C4B-65AEAD95A18BQ80259155-45740AB1-6259-470C-BC4F-A15F1674EF57Q83622535-3DEE527E-80AA-449D-9D04-2468C3046EAFQ85091562-E44710A9-5BEE-48E0-81D5-CD1DACBB08A6Q86101752-F2B53BF4-AEA1-4F8D-AAFB-C4D1C21D5541Q86531493-B1926F54-C9DC-443E-B241-8B28AB5CD93EQ89146398-F4289D62-9FD5-409C-8923-33C92555183D
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Nicolas Bonnet
@ast
Nicolas Bonnet
@en
Nicolas Bonnet
@es
Nicolas Bonnet
@nl
Nicolas Bonnet
@sl
type
label
Nicolas Bonnet
@ast
Nicolas Bonnet
@en
Nicolas Bonnet
@es
Nicolas Bonnet
@nl
Nicolas Bonnet
@sl
altLabel
ECTS ACADEMY MEMBER
@en
prefLabel
Nicolas Bonnet
@ast
Nicolas Bonnet
@en
Nicolas Bonnet
@es
Nicolas Bonnet
@nl
Nicolas Bonnet
@sl
P106
P2038
Nicolas_Bonnet2
P21
P31
P496
0000-0001-9832-5767
P569
2000-01-01T00:00:00Z